Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

24. Novembre 2025

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 11591


	Articles 1 - 20 / 231803

	The lncrnas: innovative multifunctional players of drug resistance in colorectal cancer. Cancer Cell Int Maghsoudi H, Rasoulzadeh M, Abbastabar M, Fazilat A, Sheikhnia F, Azizzadeh B, Valilo M, Majidinia M. PMID: 41276852 [PubMed - as supplied by publisher]
	Consensus Molecular Subtypes (CMS) Classification: a progress towards Subtype-Driven treatments in colorectal cancer. World J Surg Oncol Kantha A, Das D, Pai E, Kumar T, Pandey M. PMID: 41276825 [PubMed - as supplied by publisher]
	Theranostics in the management of colorectal cancer. Discov Nano Menon G, Anandan T, Kolage SM, Shenoy SC, Lohakare OK, Ahire AS, Ravindran D. PMID: 41276733 [PubMed]
	Transperitoneal versus retroperitoneal laparoscopic nephroureterectomy: a meta-analysis of technical approaches for upper tract urothelial carcinoma. Langenbecks Arch Surg Li D, Ruan Z, Lin F, Wang G, Xu J, Luo T, Chen T. PMID: 41276690 [PubMed - as supplied by publisher]
	Oncological outcomes of planned and unplanned low Hartmann's procedure and restorative low anterior resection for rectal cancer: a population-based cross-sectional study. Tech Coloproctol van Geffen EGM, Verheij FS, Hazen SMJA, Sluckin TC, Consten ECJ, Dekker JT, Nederend J, Peeters KCMJ, de Wilt JHW, van Dieren S, Hompes R, Tuynman JB, Marijnen CAM, Tanis PJ, Kusters M, Dutch Snapshot Research Group. PMID: 41276685 [PubMed - as supplied by publisher]
	Neoadjuvant pembrolizumab with a watchâ€‘andâ€‘wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 - PRODIGE 84 phase II trial (PREMICES). Dig Liver Dis Lefevre JH, Dubreuil O, Colle R, Tougeron D, Vienot A, Dupré A, Toullec C, Smith D, Guimbaud R, Chibaudel B, Garcia Larnicol ML, Vernerey D, Cohen R, PREMICES Study Group. PMID: 41276451 [PubMed - as supplied by publisher]
	MSH2 in colorectal cancer: a comprehensive review of molecular mechanisms, clinical prognosis, and a precision oncology framework. Crit Rev Oncol Hematol Zhao Y, Liu Y, Xu Y, Guo Z, Zhang X, Ma Z. PMID: 41275990 [PubMed - as supplied by publisher]
	Quality Assurance in Multi-Modality Oesophago-Gastric Cancer Clinical Trials: Past, Present and Future Perspectives. Clin Oncol (R Coll Radiol) Helbrow J, Booth ME, Vadhwana B, Adams R, Foley KG, Peters CJ, Petty RD, Gwynne S. PMID: 41275544 [PubMed - as supplied by publisher]
	Research Article: FKBP4-HSP90 Interaction in Colorectal Cancer: A Novel Therapeutic Target. Crit Rev Oncog Golivi Y, Behera SK, Peela S, Alam A. PMID: 41275478 [PubMed - indexed for MEDLINE]
	Review Article: CD151 and TGF-Î² in Colon Cancer Metastasis: Flavonoids and Their Targeted Delivery Systems. Crit Rev Oncog Malla RR, Kundrapu DB, Priyamavada B, Nagaraju GP. PMID: 41275477 [PubMed - indexed for MEDLINE]
	Overall and Site-Specific Cancer Mortality Among Older Migrants and Nonmigrants in Finland: A Population Register Study on All Deaths, 2002-2020. Cancer Med Kemppainen L, Kemppainen T, Raitanen J, Enroth L, Halonen P, Jylhä M, Kouvonen A, Pulkki J. PMID: 41275426 [PubMed - indexed for MEDLINE]
	Influence of the coronavirus disease 2019 pandemic on gastric cancer: associations with diagnostic delays, clinicopathological features, and 3-year survival. Ann Saudi Med Yar, Cin M. PMID: 41275347 [PubMed - indexed for MEDLINE]
	Small-Molecule Inhibitors Targeting PD-1/PD-L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical Prospects. ChemMedChem Wang J, Yu S, Qian L, Wu Y, Zhang W, Awadasseid A. PMID: 41275334 [PubMed - as supplied by publisher]
	A robust classifier for the intrinsic consensus molecular subtypes in colorectal cancer. J Transl Med Tsantoulis P, Hong Y, Wirapati P, Pu T, Peddle AM, Mckee T, Tejpar S. PMID: 41275314 [PubMed - as supplied by publisher]
	A machine-learning powered liquid biopsy predicts response to paclitaxel plus ramucirumab in advanced gastric cancer: results from the prospective IVY trial. Mol Cancer Shoda K, Xu C, Nagasaka T, Ichikawa D, Goel A. PMID: 41275215 [PubMed - as supplied by publisher]
	CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer. BMC Cancer Passardi A, Sullo FG, Bittoni A, Matteucci L, De Rosa F, Bulgarelli J, Tazzari M, Petrini M, Scarpi E, Testoni S, Miserocchi A, Tartagni O, Zani C, Iaia ML, Toma I, Viola MG, Mita MT, Tamburini E, Ridolfi L. PMID: 41275134 [PubMed - as supplied by publisher]
	Colorectal cancer screening, incidence, and mortality among aging veterans in the U.S. Department of Veterans Affairs healthcare system by housing status. Geroscience Beydoun HA, Murthy SS, Falker CG, Tsai J. PMID: 41275069 [PubMed - as supplied by publisher]
	Prevalence, clinicopathological features, and prognosis of diabetes in pancreatic cancer: A single-center retrospective cohort study of 1620 patients. Pancreatology Li Y, Xiang S, Zhong W, Wang S, Zhang S, Zhang J, Du Y, Wang C, Che X. PMID: 41274804 [PubMed - as supplied by publisher]
	Targeting drug-tolerant persister cells to overcome resistance in HER2-positive gastric cancer. Crit Rev Oncol Hematol Xu Q, Li L, Song S, Ding H, Liu C, Jin X, Li L, Zhang H, Zhong M, Cheng Y, Zhu J, Zhang G. PMID: 41274533 [PubMed - as supplied by publisher]
	Lipidomic machine learning predictor for progression of gastric cancer. Clin Chim Acta Ding X, Zhou J, Wang Z, Bo Y, Abliz Z, An Z, Yang F, Chen Y. PMID: 41274332 [PubMed - as supplied by publisher]

Articles 1 - 20 / 231803

Page 1 de 11591



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité